Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 907: 174247, 2021 Sep 15.
Article in English | MEDLINE | ID: mdl-34116045

ABSTRACT

Endoplasmic reticulum (ER) stress is an inflammatory response that contributes to endothelial cell dysfunction, a hallmark of cardiovascular diseases, in close interplay with oxidative stress. Recently, Sestrin2 (SESN2) emerged as a novel stress-inducible protein protecting cells from oxidative stress. We investigated here, for the first time, the impact of SESN2 suppression on oxidative stress and cell survival in human endothelial cells subjected to pharmacologically (thapsigargin)-induced ER stress and studied the underlying cellular pathways. We found that SESN2 silencing, though did not specifically induce ER stress, it aggravated the effects of thapsigargin-induced ER stress on oxidative stress and cell survival. This was associated with a dysregulation of Nrf-2, AMPK and mTORC1 signaling pathways. Furthermore, SESN2 silencing aggravated, in an additive manner, apoptosis caused by thapsigargin. Importantly, SESN2 silencing, unlike thapsigargin, caused a dramatic decrease in protein expression and phosphorylation of Akt, a critical pro-survival hub and component of the AMPK/Akt/mTORC1 axis. Our findings suggest that patients with conditions characterized by ER stress activation, such as diabetes, may be at higher risk for cardiovascular complications if their endogenous ability to stimulate and/or maintain expression levels of SESN2 is disturbed or impaired. Therefore, identifying novel or repurposing existing pharmacotherapies to enhance and/or maintain SESN2 expression levels would be beneficial in these conditions.


Subject(s)
Endoplasmic Reticulum Stress , AMP-Activated Protein Kinases , Animals , Endothelial Cells , Mechanistic Target of Rapamycin Complex 1 , Signal Transduction
2.
Biomacromolecules ; 17(7): 2375-83, 2016 07 11.
Article in English | MEDLINE | ID: mdl-27192144

ABSTRACT

Many hydrophobic drugs encounter severe bioavailability issues owing to their low aqueous solubility and limited cellular uptake. We have designed a series of amphiphilic polyaspartamide polyelectrolytes (PEs) that solubilize such hydrophobic drugs in aqueous medium and enhance their cellular uptake. These PEs were synthesized through controlled (∼20 mol %) derivatization of polysuccinimide (PSI) precursor polymer with hydrophobic amines (of varying alkyl chain lengths, viz. hexyl, octyl, dodecyl, and oleyl), while the remaining succinimide residues of PSI were opened using a protonable and hydrophilic amine, 2-(2-amino-ethyl amino) ethanol (AE). Curcumin (Cur) was employed as a representative hydrophobic drug to explore the drug-delivery potential of the resulting PEs. Unprecedented enhancement in the aqueous solubility of Cur was achieved by employing these PEs through a rather simple protocol. In the case of PEs containing oleyl/dodecyl residues, up to >65000× increment in the solubility of Cur in aqueous medium could be achieved without requiring any organic solvent at all. The resulting suspensions were physically and chemically stable for at least 2 weeks. Stable nanosized polyelectrolyte complexes (PECs) with average hydrodynamic diameters (DH) of 150-170 nm (without Cur) and 220-270 nm (after Cur loading) were obtained by using submolar sodium polyaspartate (SPA) counter polyelectrolyte. The zeta potential of these PECs ranged from +36 to +43 mV. The PEC-formation significantly improved the cytocompatibility of the PEs while affording reconstitutable nanoformulations having up to 40 wt % drug-loading. The Cur-loaded PECs were readily internalized by mammalian cells (HEK-293T, MDA-MB-231, and U2OS), majorly through clathrin-mediated endocytosis (CME). Cellular uptake of Cur was directly correlated with the length of the alkyl chain present in the PECs. Further, the PECs significantly improved nuclear transport of Cur in cancer cells, resulting in their death by apoptosis. Noncancerous cells were completely unaffected under this treatment.


Subject(s)
Curcumin/chemistry , Curcumin/pharmacology , Drug Delivery Systems , Nanocomposites/chemistry , Neoplasms/drug therapy , Polyelectrolytes/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cell Membrane Permeability , Cell Survival/drug effects , Drug Carriers , Hemolysis/drug effects , Humans , Hydrophobic and Hydrophilic Interactions , Nanocomposites/administration & dosage , Solubility
3.
J Biomed Mater Res B Appl Biomater ; 102(6): 1244-54, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24500854

ABSTRACT

We report the preparation of plasma microparticles (PMPs) from autologous blood plasma for sustained in vivo delivery of the entrapped antigens. The PMPs were prepared by high speed-stirring of calcium-enriched plasma, mixed with the antigen to be entrapped, in mineral oil. The preparation of PMPs did not necessitate addition of any external protein/enzyme nor special laboratory setup. Our results suggest that the PMPs release the entrapped invertase in a sustained manner both in vitro and in vivo, especially after crosslinking with glutaraldehyde. The preparations are reasonably stable to proteolysis and constitute strong candidates for eliciting immune response. Induction of humoral immune response by the PMP-entrapped invertase, as evident from the high antibody titers, was remarkable and comparable with that observed in animals receiving the antigen emulsified with Freund's Complete Adjuvant. Isotypic analysis of antibodies showed a Th1-biased immune response in animals administered uncrosslinked or crosslinked PMPs-entrapped invertase, especially after a booster dose. The analysis in animals of the group immunized with adjuvant-emulsified antigen suggested a combined Th1 and Th2 response. PMP-entrapment also caused high expression of surface markers (CD80 and CD86) on antigen presenting cells, as well as effector T-cells surface markers (CD4(+) and CD8(+) ) as revealed by FACS. The study suggests that PMPs offer remarkable promise as adjuvant-free and biocompatible vaccine delivery systems.


Subject(s)
Antigens , Cell-Derived Microparticles/chemistry , Drug Delivery Systems , Immunization/methods , Mineral Oil , Plasma/chemistry , Animals , Antigens/chemistry , Antigens/immunology , Antigens/pharmacology , CD8-Positive T-Lymphocytes , Cell-Derived Microparticles/immunology , Mice , Mice, Inbred BALB C , Mineral Oil/chemistry , Mineral Oil/pharmacology , Plasma/immunology , Rabbits , Th1 Cells/immunology , Th2 Cells/immunology
4.
Vaccine ; 30(48): 6851-8, 2012 Nov 06.
Article in English | MEDLINE | ID: mdl-23044405

ABSTRACT

The development of a prophylactic vaccine against systemic candidiasis, employing Candida albicans cytosolic proteins (Cp) as antigen and fibrin cross-linked plasma beads as an antigen bearing dual delivery system is described. Groups of mice were administered either with free Cp, or Cp entrapped in plasma beads, Cp entrapped in liposomes or liposome encapsulated Cp further entrapped in plasma beads. Humoral immunity was studied by measuring the anti-Cp antibody titers in the sera of the immunized animals. Induction of cell-mediated immunity was assessed by delayed type hypersensitivity (DTH), NO production, up-regulation of co-stimulatory molecules viz. CD80, CD86 on APCs on one hand and T-cells proliferation as well as induction of IFN-γ and IL-4 on the other. The efficacy of various vaccine formulations in protecting mice against a lethal challenge with C. albicans, was assessed by determining animal survival rate and fungal burden in the systemic circulation and vital organs. Among various Cp-based vaccines investigated, the preparation containing liposomized Cp entrapped in plasma beads imparted superior protection in the immunized mice as compared to other antigens delivery systems.


Subject(s)
Antigens, Fungal/immunology , Candida albicans/immunology , Candidiasis/prevention & control , Drug Carriers/administration & dosage , Plasma/metabolism , Animals , Antibodies, Fungal/blood , Antigen-Presenting Cells/chemistry , Antigen-Presenting Cells/immunology , Antigens, CD/analysis , Antigens, Fungal/administration & dosage , Candidiasis/immunology , Cell Proliferation , Disease Models, Animal , Female , Hypersensitivity, Delayed , Interferon-gamma/metabolism , Interleukin-4/metabolism , Liposomes/administration & dosage , Mice , Mice, Inbred BALB C , Survival Analysis , T-Lymphocytes/immunology
5.
Ther Deliv ; 2(5): 573-83, 2011 May.
Article in English | MEDLINE | ID: mdl-22833975

ABSTRACT

AIM: The aim of the study was to prepare a drug-entrapped, beaded form of blood plasma for possible sustained drug delivery. METHOD: Blood plasma mixed with various drugs was enriched with CaCl2 and transferred in the form of small droplets on to a glass slide covered with parafilm. Clot formation was induced by incubation at 37 degrees C. RESULTS: Plasma-bead entrapped tetracycline, amphotericin B and daunorubicin were released gradually in vitro. Crosslinking of the beads with glutaraldehyde decreased the release rate of drugs remarkably. The plasma bead-entrapped cefotaxime administered subcutaneously in mice was released in a slow and sustained fashion and remained in circulation for a longer duration than the antibiotic administered in the free form. CONCLUSION: The plasma beads have potential for the sustained delivery of drugs in vivo, since their preparation does not require additional thrombin or other proteins and can be readily accomplished by using autologous plasma, thereby minimizing the risk of immunological complications.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Drug Delivery Systems , Animals , Delayed-Action Preparations , Mice , Mice, Inbred BALB C , Plasma
SELECTION OF CITATIONS
SEARCH DETAIL
...